These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26964748)
1. Analytical detection and characterization of biopharmaceutical glycosylation by MS. Oh MJ; Hua S; Kim U; Kim HJ; Lee J; Kim JH; An HJ Bioanalysis; 2016 Apr; 8(7):711-27. PubMed ID: 26964748 [TBL] [Abstract][Full Text] [Related]
2. Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. Oh MJ; Hua S; Kim BJ; Jeong HN; Jeong SH; Grimm R; Yoo JS; An HJ Bioanalysis; 2013 Mar; 5(5):545-59. PubMed ID: 23425271 [TBL] [Abstract][Full Text] [Related]
3. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062 [TBL] [Abstract][Full Text] [Related]
4. Current landscape of protein glycosylation analysis and recent progress toward a novel paradigm of glycoscience research. Yamamoto S; Kinoshita M; Suzuki S J Pharm Biomed Anal; 2016 Oct; 130():273-300. PubMed ID: 27461579 [TBL] [Abstract][Full Text] [Related]
5. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications. Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805 [TBL] [Abstract][Full Text] [Related]
6. Physicochemical Characterization, Glycosylation Pattern and Biosimilarity Assessment of the Fusion Protein Etanercept. Montacir O; Montacir H; Springer A; Hinderlich S; Mahboudi F; Saadati A; Parr MK Protein J; 2018 Apr; 37(2):164-179. PubMed ID: 29411222 [TBL] [Abstract][Full Text] [Related]
7. Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry. Gan Y; Lippold S; Stobaugh J; Schöneich C; Yang F MAbs; 2024; 16(1):2395503. PubMed ID: 39192481 [TBL] [Abstract][Full Text] [Related]
8. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis. D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257 [TBL] [Abstract][Full Text] [Related]
9. N-glycan Analysis in Molecular Medicine: Innovator and Biosimilar Protein Therapeutics. Borza B; Hajba L; Guttman A Curr Mol Med; 2020; 20(10):828-839. PubMed ID: 33272172 [TBL] [Abstract][Full Text] [Related]
10. Discrepancies between High-Resolution Native and Glycopeptide-Centric Mass Spectrometric Approaches: A Case Study into the Glycosylation of Erythropoietin Variants. Čaval T; Buettner A; Haberger M; Reusch D; Heck AJR J Am Soc Mass Spectrom; 2021 Aug; 32(8):2099-2104. PubMed ID: 33856811 [TBL] [Abstract][Full Text] [Related]
11. Orthogonal liquid chromatography-mass spectrometry methods for the comprehensive characterization of therapeutic glycoproteins, from released glycans to intact protein level. Largy E; Cantais F; Van Vyncht G; Beck A; Delobel A J Chromatogr A; 2017 May; 1498():128-146. PubMed ID: 28372839 [TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods. Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M MAbs; 2015; 7(4):732-42. PubMed ID: 25996192 [TBL] [Abstract][Full Text] [Related]
13. Automated High-Throughput Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS. Shubhakar A; Kozak RP; Reiding KR; Royle L; Spencer DI; Fernandes DL; Wuhrer M Anal Chem; 2016 Sep; 88(17):8562-9. PubMed ID: 27479043 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS. Liu S; Gao W; Wang Y; He Z; Feng X; Liu BF; Liu X PLoS One; 2017; 12(1):e0170013. PubMed ID: 28072827 [TBL] [Abstract][Full Text] [Related]
15. Improvement of mass spectrometry analysis of glycoproteins by MALDI-MS using 3-aminoquinoline/α-cyano-4-hydroxycinnamic acid. Watanabe M; Terasawa K; Kaneshiro K; Uchimura H; Yamamoto R; Fukuyama Y; Shimizu K; Sato TA; Tanaka K Anal Bioanal Chem; 2013 May; 405(12):4289-93. PubMed ID: 23380952 [TBL] [Abstract][Full Text] [Related]
16. Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm. Ethier M; Krokhin O; Ens W; Standing KG; Wilkins JA; Perreault H Rapid Commun Mass Spectrom; 2005; 19(5):721-7. PubMed ID: 15702487 [TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics. Schiel JE; Au J; He HJ; Phinney KW Anal Bioanal Chem; 2012 Jun; 403(8):2279-89. PubMed ID: 22354569 [TBL] [Abstract][Full Text] [Related]
18. Glycan characterization of biopharmaceuticals: Updates and perspectives. Planinc A; Bones J; Dejaegher B; Van Antwerpen P; Delporte C Anal Chim Acta; 2016 May; 921():13-27. PubMed ID: 27126786 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the glycosylation pattern of plant copper amine oxidases by MALDI-TOF/TOF MS coupled to a manual chromatographic separation of glycans and glycopeptides. Franc V; Řehulka P; Medda R; Padiglia A; Floris G; Šebela M Electrophoresis; 2013 Aug; 34(16):2357-67. PubMed ID: 23580492 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry. Selman MH; McDonnell LA; Palmblad M; Ruhaak LR; Deelder AM; Wuhrer M Anal Chem; 2010 Feb; 82(3):1073-81. PubMed ID: 20058878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]